We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Robotic-Assisted Bronchoscopy Platform Offers Minimally Invasive Option for Lung Biopsy

By HospiMedica International staff writers
Posted on 08 Jul 2024
Print article
Image: The Ion robotic-assisted platform is designed to elevate performance in lung biopsy care (Photo courtesy of Intuitive Surgical)
Image: The Ion robotic-assisted platform is designed to elevate performance in lung biopsy care (Photo courtesy of Intuitive Surgical)

Bronchoscopy is a longstanding method for diagnosing lung cancer, particularly effective for detecting early-stage lesions (Stages 1 - 2). Commonly, lung cancers are identified when the nodule or spot has grown significantly, with cure rates ranging between 64-70% for tumors approximately 30mm in size, assuming no further metastasis has occurred. Diagnosing nodules in the peripheral lung presents additional challenges due to the narrowing and bending of the bronchi, which can obstruct the bronchoscope's path. This often necessitates multiple biopsies before a definitive diagnosis, potentially prolonging a patient’s pathway to treatment. Now, a minimally invasive bronchoscopy platform helps shorten the patient journey by enabling access to and biopsy of hard-to-reach nodules in the peripheral lung, where over 70% of cancerous lung nodules are found.

Intuitive Surgical’s (Sunnyvale, CA, USA) Ion (Ion endoluminal system) represents a significant advancement in diagnostic technology, facilitating robotic-assisted tissue sample collection from virtually any lung nodule. Ion’s highly flexible, maneuverable catheter allows clinicians to access small lesions across all 18 lung segments with greater reach, precision, and stability. This capability ensures the safe and efficient collection of lung tissue samples for biopsy, even when nodules are small and situated in hard-to-reach peripheral locations. Ion is distinctive in that it employs shape-sensing technology to provide continuous, precise feedback on the catheter’s location, shape, and orientation by measuring its form hundreds of times per second during navigation and biopsy.

Ion provides a comprehensive view of the catheter’s position within the airway through a 3D real-time visualization made possible by shape-sensing technology. Additionally, Ion offers 2D direct visualization at the tip via a vision probe. The camera and biopsy tools are accommodated within the same channel, maintaining the catheter's ultra-thin diameter, which is crucial for navigating narrow passages and sharp turns. Real-time shape sensing aids in visual positioning and orientation, enhancing navigation and biopsy accuracy. The catheter, which can articulate 180° in any direction, features a thin fiber optic shape sensor embedded within a 3.5 mm outer diameter wall with a 2 mm working channel. It responds dynamically to physician commands via Ion’s trackball and scroll wheel. Advanced real-time shape-sensing technology combined with robotic control algorithms enables the Ion catheter to maintain its position once the target nodule is reached. The Ion system integrates seamlessly with Siemens Healthineers’ (Forchheim, Germany) Cios Spin mobile imaging system to perform 3D scans that are automatically transmitted to Ion, allowing physicians to refine navigation and confirm tool-in-lesion using a touchscreen.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
Surgical Needle

Print article


Critical Care

view channel
Image: A new study has validated a diagnostic tool for identifying amyloid beta plaques, a key hallmark of Alzheimer’s disease (Photo courtesy of Shutterstock)

Diagnostic Tool Identifies Amyloid Beta Plaques in Alzheimer’s Disease Patients

Amyloid PET scans are known for providing in-vivo evidence of Alzheimer's Disease (AD) pathology. However, their high cost restricts widespread use in clinical settings. An alternative diagnostic tool,... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.